Published in Clin Exp Immunol on August 01, 2006
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol (2006) 1.47
Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol (2009) 1.14
Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol (2009) 1.09
Macrophages directly mediate diabetic renal injury. Am J Physiol Renal Physiol (2013) 1.00
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. Kidney Int (2015) 0.97
Toll-like receptor 2 is required for LPS-induced Toll-like receptor 4 signaling and inhibition of ion transport in renal thick ascending limb. J Biol Chem (2012) 0.95
Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol (2012) 0.94
Heat shock protein 70 upregulation by geldanamycin reduces brain injury in a mouse model of intracerebral hemorrhage. Neurochem Int (2010) 0.91
15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. J Clin Immunol (2008) 0.89
CaMKIV-dependent preservation of mTOR expression is required for autophagy during lipopolysaccharide-induced inflammation and acute kidney injury. J Immunol (2014) 0.87
Sepsis-induced acute kidney injury. Indian J Crit Care Med (2010) 0.86
Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol (2009) 0.84
Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy. Neurosci Lett (2010) 0.81
Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression. J Biol Chem (2012) 0.81
Selective Toll--like receptor expression in human fetal lung. Pediatr Res (2010) 0.81
Toll-like receptor 2 mediates inhibition of HCO(3)(-) absorption by bacterial lipoprotein in medullary thick ascending limb. Am J Physiol Renal Physiol (2010) 0.81
Regulation of P-glycoprotein in renal proximal tubule epithelial cells by LPS and TNF-alpha. J Biomed Biotechnol (2010) 0.80
Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy. Vet Res (2011) 0.79
Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats. J Diabetes Res (2015) 0.78
IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells. Inflamm Res (2010) 0.78
Cellular responses to HSV-1 infection are linked to specific types of alterations in the host transcriptome. Sci Rep (2016) 0.78
Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis. Clin Exp Immunol (2012) 0.77
Renal HIV expression is unaffected by serum LPS levels in an HIV transgenic mouse model of LPS induced kidney injury. PLoS One (2011) 0.77
LPS-induced delayed preconditioning is mediated by Hsp90 and involves the heat shock response in mouse kidney. PLoS One (2014) 0.76
Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist. BMC Genomics (2015) 0.75
Reducing background cytokine expression in epithelial cells without serum starvation. MethodsX (2014) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Innate immune recognition. Annu Rev Immunol (2001) 26.65
The immunopathogenesis of sepsis. Nature (2002) 11.83
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A (2000) 9.67
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem (1999) 7.81
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med (1999) 7.62
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol (2002) 5.41
A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26
The tumor necrosis factor ligand and receptor families. N Engl J Med (1996) 4.49
Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci (2002) 3.29
In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol (2002) 2.76
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol (2000) 2.41
The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon (2003) 2.39
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis (1999) 2.23
Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med (2003) 2.05
Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol (2002) 1.98
Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol (2000) 1.94
Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun (2002) 1.85
Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol (1999) 1.75
Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol (2002) 1.66
Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol (2001) 1.50
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun (2004) 1.48
Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun (1997) 1.38
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol (1998) 1.38
Rapid reduction of MDCK cell cholesterol by methyl-beta-cyclodextrin alters steady state transepithelial electrical resistance. Eur J Cell Biol (1999) 1.37
Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol (2000) 1.36
Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int (2005) 1.35
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock (1995) 1.32
P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol Microbiol (1999) 1.14
Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med (2001) 1.06
Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-gamma. Am J Pathol (2003) 0.96
Expression of Toll-like receptors in the kidney: their potential role beyond infection. Kidney Int (2006) 0.83
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am J Transplant (2006) 1.51
Urinary tract infections: new insights into a common problem. Postgrad Med J (2005) 1.44
Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med (1993) 1.39
Late strut fracture in a Björk-Shiley valve prosthesis (current series). Br Heart J (1984) 1.24
The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation (2001) 1.20
In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol (2000) 1.12
Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin Exp Immunol (1997) 1.06
Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med (2001) 1.06
Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol (1999) 1.01
Accurate intracellular localization of HLA-DM requires correct spacing of a cytoplasmic YTPL targeting motif relative to the transmembrane domain. Eur J Immunol (1999) 1.01
TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int (1997) 1.00
Protection and injury: the differing roles of complement in the development of glomerular injury. Eur J Immunol (2001) 1.00
Intrarenal synthesis of complement. Kidney Int (2001) 0.97
Human blood group isoantigen expression on normal and malignant gastric epithelium studied with anti-A and anti-B monoclonal antibodies. J Natl Cancer Inst (1983) 0.95
Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol (1996) 0.93
Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol (1999) 0.91
Interferon-gamma regulation of C4 gene expression in cultured human glomerular epithelial cells. Eur J Immunol (1993) 0.89
Coexpression of donor peptide/recipient MHC complex and intact donor MHC: evidence for a link between the direct and indirect pathways. Am J Transplant (2011) 0.89
The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol (2004) 0.89
Chronic dermal sinuses as a manifestation of histiocytosis X. Br Med J (Clin Res Ed) (1986) 0.88
Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol (2002) 0.88
Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure. Kidney Int (1997) 0.87
Reimplantation of the ureter after unilateral ureteral obstruction provides a model that allows functional evaluation. Kidney Int (2008) 0.86
To breast feed or not to breast feed. A survey of primiparae. Practitioner (1976) 0.86
Monoclonal anti-B as a new blood-typing reagent. Vox Sang (1981) 0.85
Metallurgical analysis of failed Björk-Shiley cardiac valve prostheses. Thorax (1986) 0.85
Outcome of pregnancy in an Oxford-Cardiff cohort of women with previous bacteriuria. Q J Med (1992) 0.85
Complement in renal transplantation. Nephron Clin Pract (2003) 0.85
Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts. Transplantation (1995) 0.85
Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol (1995) 0.84
Allograft immune response with sCR1 intervention. Transpl Immunol (1996) 0.84
Acute interstitial nephritis associated with Mycoplasma pneumoniae infection. Nephrol Dial Transplant (1994) 0.84
Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin Exp Immunol (2002) 0.83
Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcome. Transplantation (1994) 0.83
Verrucous carcinoma of the temporal bone. Ann Otol Rhinol Laryngol (1986) 0.83
Compartmental localization of complement component transcripts in the normal human kidney. Nephron (1998) 0.83
Strategies for targeting complement inhibitors in ischaemia/reperfusion injury. Mol Immunol (2000) 0.83
Mechanisms of nephrotoxicity. Transplantation (2000) 0.83
Fracture, separation, and aspiration of tracheostomy tubes: management with a new technique. Otolaryngol Head Neck Surg (1987) 0.81
In vitro erythrophagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron. Nephrol Dial Transplant (1999) 0.81
Intraglomerular C3 synthesis in rats with passive Heymann nephritis. Am J Pathol (1997) 0.81
Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid. Clin Exp Immunol (2004) 0.80
Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis (2001) 0.80
Up-regulation of type 1 plasminogen activator inhibitor messenger RNA with thrombotic changes in renal grafts. Transplantation (1996) 0.80
Complement synthesis in the injured kidney: does it have a role in immune complex glomerulonephritis? J Am Soc Nephrol (1996) 0.80
Complement polymorphisms: geographical distribution and relevance to disease. Immunobiology (2011) 0.80
Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am J Transplant (2012) 0.79
Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines. Ther Immunol (1994) 0.78
An antibody combination that targets activated T cells extends graft survival in sensitized recipients. Am J Transplant (2008) 0.78
Rapid rejection of HLA-A2 transgenic skin graft due to indirect allorecognition. Transplantation (2001) 0.78
Tissue synthesis of complement as an immune regulator. Mol Med Today (1995) 0.78
SPECT/CT lymphoscintigraphy of heterotopic cardiac grafts reveals novel sites of lymphatic drainage and T cell priming. Am J Transplant (2011) 0.78
Influence of complement on the allospecific antibody response to a primary vascularized organ graft. Eur J Immunol (1997) 0.78
Chronic interstitial damage in proteinuria. Does complement mediate tubulointerstitial injury? Kidney Blood Press Res (1999) 0.77
Complement and complement inhibitors: their role in autoimmune and inflammatory diseases. Curr Opin Nephrol Hypertens (1998) 0.77
Altered distribution of intraglomerular immune complexes in C3-deficient mice. Immunology (1999) 0.77
Targeting the complement system. Curr Opin Nephrol Hypertens (1999) 0.77
The local production of complement in the pathogenesis of renal inflammation. Nephrologie (1999) 0.76
Rapamycin on trial. Nephrol Dial Transplant (1999) 0.76
Local tissue complement synthesis--fine tuning a blunt instrument. Arch Immunol Ther Exp (Warsz) (2001) 0.76
Unusual presentations of anti-glomerular basement membrane antibody mediated disease are associated with delayed diagnosis and poor outcome. Clin Nephrol (1995) 0.75
Successful pregnancy in cystinosis. JAMA (1994) 0.75
Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells. Immunology (1998) 0.75
Analysis of activated T cell infiltrates in rat renal allografts by gamma camera imaging after injection of 123iodine-interleukin 2. Transpl Immunol (1993) 0.75
Direct visualisation of cytomegalovirus-specific CD8+ T cells in renal transplant recipients. Transplant Proc (2002) 0.75
Rhesus immunization after renal transplantation. Transplantation (1996) 0.75
Autoimmune renal injury in C3- and C4-deficient mice: a histological and functional study. Nephron Exp Nephrol (2004) 0.75
Dynamics of the expression of the interleukin-2 (IL-2) receptor in rat renal allografts analyzed by immunohistology, autoradiography, and nuclear imaging using radioiodinated IL-2 probes. Transplantation (1994) 0.75
Prevalence and outcome of renal impairment at prostatectomy. Br J Urol (1993) 0.75
Severe intestinal oedema due to nephrotic syndrome. QJM (2012) 0.75
Penetrating injuries of the larynx. Ear Nose Throat J (1985) 0.75
Urinary tract infections: advances and new therapies. BJU Int (2004) 0.75
IgA-associated renal diseases. Curr Opin Nephrol Hypertens (1996) 0.75
Early prediction of treatment outcome in idiopathic membranous nephropathy. QJM (1995) 0.75
Evidence for increased synthesis of complement C4 in the renal epithelium of rats with passive Heymann nephritis. J Am Soc Nephrol (1997) 0.75
From malaria to transplantation: the evolution of treatment for the nephrotic syndrome in a single patient. Nephrol Dial Transplant (1999) 0.75
Natural killer cell regulatory receptor changes following tolerance induction. Transplant Proc (2001) 0.75
Modified radical neck dissections necessitated by a retropharyngeal abscess. N Y State J Med (1987) 0.75